Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

VGK vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, VGK returned +10.4% to XBI's +41.2%, and VGK charges 0.06% to XBI's 0.35%.

askIQ about this page

askIQ about VGK and XBI

Net assets: $29.6bn on Sep 30, 2026 for Vanguard FTSE Europe ETF, and $10.3bn on Oct 27, 2026 for State Street SPDR S&P Biotech ETF.

At a glance
+10.4%
VGK total return, 1 year
+41.2%
XBI total return, 1 year
0.06%
VGK expense ratio
0.35%
XBI expense ratio

Pair scorecard

VGK costs 0.29 points a year less; their one-year returns differ by 30.8 points; VGK is 2.8 times larger.

VGK vs XBI: Differences, Returns & Fees
MeasureVGKXBI
Return
Total return, 1 year+10.4%+41.2%
Drawdown
Below its high6.1%, high on Aug 25, 2026
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksFTSE Developed Europe All Cap IndexBiotech
Cost and size
Expense ratio0.06%0.35%
Net assets, as of Sep 30, 2026$29.6bn$10.4bn
Active share vs the S&P 50098%
Holdings
Holdings in common0%
Top ten holdings, share of the fund19.0%18%

Holdings in common uses holdings dated Sep 30, 2026 and Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, VGK and XBI hold 0% of their money in the same securities at the same weight. Holdings dated Sep 30, 2026 and Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first VGK XBI
Only in one fund ↓
Only in VGK
ASML Holding NV 4.47%
HSBC Holdings PLC 2.19%
Roche Holding AG 1.89%
Novartis AG 1.72%
Shell PLC 1.64%
AstraZeneca PLC 1.56%
Nestle SA 1.51%
Siemens AG 1.45%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
AMGEN INC 1.68%
ABBVIE INC 1.67%
Check overlap with more funds →

Side by side

VGK Vanguard FTSE Europe ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Stock ETF Thematic ETF
What it is Tracks an index of European Stock Biotech
Total return, 1 year +10.4% +41.2%
Expense ratio 0.06% 0.35%
Already in the S&P 500 0.0% 13.2%
Holdings 1245 165
Net assets, VGK as of Sep 30, 2026 and XBI as of Oct 27, 2026 $29.6bn $10.3bn

VGK and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
VGK

VGK tracks an index of European Stock. Over the year to Oct 28, 2026 it returned +10.4% with distributions reinvested. The prospectus expense ratio is 0.06% a year. By its holdings published by its issuer as of Sep 30, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 1,245 positions, with the top ten at 19.0%. It sat 6.1% below its high of Aug 25, 2026 on Oct 28, 2026.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are VGK and XBI in the same category?
VGK is a stock ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, VGK or XBI?
In the year to Oct 28, 2026, with distributions reinvested, VGK returned +10.4% and XBI +41.2%.
Which is cheaper, VGK or XBI?
VGK is cheaper, by 0.29 percentage points a year. That is about $29 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do VGK and XBI overlap with the S&P 500?
By their latest filed holdings, 0% of VGK and 13% of XBI by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, VGK against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/vgk-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.